Clinical Trial Update: Siltuximab in Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for siltuximab in schizophrenia exploring Phase 1 and Phase 2 data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• Siltuximab (siltuximab)

Snippet

Sponsor: Brian Miller | Conditions: Schizophrenia, Psychotic Disorders | Phase 1, Phase 2 | Status: UNKNOWN